Treatment of Vaccinial Keratitis With Vidarabine
Robert A. Hyndiuk, Masao Okumoto, Reply Damiano, Mario J. Valenton, Gilbert Smolin
Abstract
Robert A. Hyndiuk, Masao Okumoto, Reply Damiano, Mario J. Valenton, Gilbert Smolin
Abstract
Vaccinial epithelial keratitis was produced in rabbits. When the therapeutic effect of vidarabine on the experimentally-induced disease was evaluated and compared to the effect of idoxuridine, vidarabine was found to be highly effective, substantially more effective than idoxuridine, and nontoxic to the eye.
OpenAlex reports 29 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Vaccinial epithelial keratitis was produced in rabbits. When the therapeutic effect of vidarabine on the experimentally-induced disease was evaluated and compared to the effect of idoxuridine, vidarabine was found to be highly effective, substantially more effective than idoxuridine, and nontoxic to the eye.
Key concepts: Vidarabine, Keratitis, Medicine, Ophthalmology, Dermatology, Optometry, Surgery, Chemotherapy